Millennium Management’s Acceleron Pharma XLRN Stock Holding History

Millennium Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-129,600	Closed	-$22.3M	–	7799
2021 Q3	$22.3M	Buy	+129,600	New	+$17M	0.01%	1222
2018 Q3	–	Sell	-68,600	Closed	-$3.33M	–	4431
2018 Q2	$3.33M	Buy	68,600 +18,600	+37%	+$678K	﹤0.01%	2070
2018 Q1	$1.96M	Buy	+50,000	New	+$2.13M	﹤0.01%	2337

Millennium Management's XLRN Position: Q4 2021 in Review

Millennium Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 273,520 shares — an estimated $47.1M sold.

Millennium Management first reported a position in XLRN in Q2 2014 and held it in 23 quarters. The position peaked at $47.1M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Millennium Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Millennium Management sold 273,520 Acceleron Pharma shares in Q4 2021, an estimated $47.1M.
Millennium Management first reported a position in Acceleron Pharma in Q2 2014 and held it in 23 quarters.
Millennium Management's Acceleron Pharma position peaked at $47.1M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.